JP Morgan Maintains Overweight on Imax, Lowers Price Target to $47
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Overweight and lowers the price target from $48 to $47.
JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Overweight and lowers the price target from $48 to $47.